Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon M Rushbrook

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
JHEP Reports : Innovation in Hepatology|September 24, 2024
Regulation of intestinal senescence during cholestatic liver disease modulates barrier function and liver disease progressionMar Moreno-Gonzalez, Katherine Hampton, Paula Ruiz, et al.
Gut|September 28, 2023
British Society of Gastroenterology guidelines for the diagnosis and management of cholangiocarcinomaSimon M Rushbrook, Timothy James Kendall, Yoh Zen, et al.
Gut|August 19, 2024
Guidelines Development Group for the British Society of Gastroenterology guidelines for the diagnosis and management of cholangiocarcinomaShahid A Khan, Simon M Rushbrook, Timothy James Kendall, et al.
BMJ Open|March 10, 2019
Top research priorities in liver and gallbladder disorders in the UKKurinchi S Gurusamy, Martine Walmsley, Brian R Davidson, et al.
Hepatology (Baltimore, Md.)|September 20, 2018
Fine-Tuning of Sirtuin 1 Expression Is Essential to Protect the Liver From Cholestatic Liver DiseaseBritt A Blokker, Monica Maijo, Marta Echeandia, et al.
Nature Communications|February 24, 2023
Multitrait genome-wide analyses identify new susceptibility loci and candidate drugs to primary sclerosing cholangitisYounghun Han, Jinyoung Byun, Catherine Zhu, et al.
Hepatology (Baltimore, Md.)|December 20, 2018
Factors Associated With Outcomes of Patients With Primary Sclerosing Cholangitis and Development and Validation of a Risk Scoring SystemElizabeth C Goode, Allan B Clark, George F Mells, et al.
Gut|August 6, 2017
Genetic association analysis identifies variants associated with disease progression in primary sclerosing cholangitisRudi Alberts, Elisabeth M G de Vries, Elizabeth C Goode, et al.
Nature Genetics|December 20, 2016
Genome-wide association study of primary sclerosing cholangitis identifies new risk loci and quantifies the genetic relationship with inflammatory bowel diseaseSun-Gou Ji, Brian D Juran, Sören Mucha, et al.
Nature Genetics|April 23, 2013
Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitisJimmy Z Liu, Johannes Roksund Hov, Trine Folseraas, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
JHEP Reports : Innovation in Hepatology|September 24, 2024
Regulation of intestinal senescence during cholestatic liver disease modulates barrier function and liver disease progressionMar Moreno-Gonzalez, Katherine Hampton, Paula Ruiz, et al.
Gut|September 28, 2023
British Society of Gastroenterology guidelines for the diagnosis and management of cholangiocarcinomaSimon M Rushbrook, Timothy James Kendall, Yoh Zen, et al.
Gut|August 19, 2024
Guidelines Development Group for the British Society of Gastroenterology guidelines for the diagnosis and management of cholangiocarcinomaShahid A Khan, Simon M Rushbrook, Timothy James Kendall, et al.
BMJ Open|March 10, 2019
Top research priorities in liver and gallbladder disorders in the UKKurinchi S Gurusamy, Martine Walmsley, Brian R Davidson, et al.
Hepatology (Baltimore, Md.)|September 20, 2018
Fine-Tuning of Sirtuin 1 Expression Is Essential to Protect the Liver From Cholestatic Liver DiseaseBritt A Blokker, Monica Maijo, Marta Echeandia, et al.
Nature Communications|February 24, 2023
Multitrait genome-wide analyses identify new susceptibility loci and candidate drugs to primary sclerosing cholangitisYounghun Han, Jinyoung Byun, Catherine Zhu, et al.
Hepatology (Baltimore, Md.)|December 20, 2018
Factors Associated With Outcomes of Patients With Primary Sclerosing Cholangitis and Development and Validation of a Risk Scoring SystemElizabeth C Goode, Allan B Clark, George F Mells, et al.
Gut|August 6, 2017
Genetic association analysis identifies variants associated with disease progression in primary sclerosing cholangitisRudi Alberts, Elisabeth M G de Vries, Elizabeth C Goode, et al.
Nature Genetics|December 20, 2016
Genome-wide association study of primary sclerosing cholangitis identifies new risk loci and quantifies the genetic relationship with inflammatory bowel diseaseSun-Gou Ji, Brian D Juran, Sören Mucha, et al.
Nature Genetics|April 23, 2013
Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitisJimmy Z Liu, Johannes Roksund Hov, Trine Folseraas, et al.
Pageof 3